Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference102 articles.
1. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review;Hutchinson;Eur Respir J,2015
2. Epidemiology of interstitial lung diseases in Greece;Karakatsani;Respir Med,2009
3. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype;Olson;Eur Respir Rev,2018
4. Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001-2013;Marshall;Eur Respir J,2018
5. What have we learned from basic science studies on idiopathic pulmonary fibrosis?;Yanagihara;Eur Respir Rev,2019
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Precision medicine for respiratory diseases: A current viewpoint;Medicine International;2024-04-12
2. Precision medicine advances in idiopathic pulmonary fibrosis;eBioMedicine;2023-09
3. Recent Advances of Artificial Intelligence Applications in Interstitial Lung Diseases;Diagnostics;2023-07-06
4. Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA Methylation;Biomedicines;2023-03-28
5. Fibromine is a multi-omics database and mining tool for target discovery in pulmonary fibrosis;Scientific Reports;2021-11-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3